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Abstract Bridging conduits (BC) sustain communication
and homeostasis between distant tethered cells. These are
also exploited commonly for direct cell-to-cell transfer of
microbial agents. Conduits efficiently spread infection,
effectively, at speeds faster than fluid phase exchange while
shielding the microbe against otherwise effective humoral
immunity. Our laboratory has sought to uncover the
mechanism(s) for these events for human immunodeficiency
virus type one (HIV-1) infection. Indeed, in our prior works
HIV-1 Env and Gag antigen and fluorescent virus tracking
were shown sequestered into endoplasmic reticulum-Golgi
organelles but the outcomes for spreading viral infection
remained poorly defined. Herein, we show that HIV-1
specifically traffics through endocytic compartments
contained within BC and directing such macrophage-to-
macrophage viral transfers. Following clathrin-dependent
viral entry, HIV-1 constituents bypass degradation by
differential sorting from early to Rab11
+ recycling endo-
somes and multivesicular bodies. Virus-containing endo-
cytic viral cargoes propelled by myosin II through BC
spread to neighboring uninfected cells. Disruption of
endosomal motility with cytochalasin D, nocodasole and
blebbistatin diminish intercellular viral spread. These data
lead us to propose that HIV-1 hijacks macrophage
endocytic and cytoskeletal machineries for high-speed
cell-to-cell spread.
Keywords HIV-1.Macrophage.Bridging conduits.
Tunneling nanotubes.Recycling endosomes.
Multivesicular bodies.Viral trafficking.Endocytic sorting.
Lysosomes.Early endosomes.Motor proteins.Tubulin.
Intercellular viral spread
Introduction
Retroviruses exploit subcellular structures to facilitate
infection and evade immune surveillance. One of these is
bridging conduits (BC), also referred to as tunneling
nanotubes, that serve to tether distant cells (Gerdes et al.
2007; Xu et al. 2009). For mononuclear phagocytes (MP;
monocytes, macrophages and dendritic cells) such conduits
serve as cytoplasmic extensions that facilitate open-ended
bidirectional exchange of cellular organelles and proteins
amongst cells (Kadiu and Gendelman 2011). They also
affect intercellular communication and can facilitate micro-
bial infections (Chinnery et al. 2008; Onfelt et al. 2006;X u
et al. 2009; Kadiu and Gendelman 2011). The human
immunodeficiency virus type one (HIV-1) may exploit such
high-speed intercellular conduit communication links to
accelerate spread of infection in lymphoid and neural tissues.
Persistent viral replication would then ensue even during
robust humoral immune responses (Gousset et al. 2009;
Sowinski et al. 2008). HIV-1 Env, Gag, and Nef were
identified in BC (Eugenin et al. 2009a, b; Sowinski et al.
2008;X ue ta l .2009). However, it remained unclear whether
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viral particulates sequestered into endocytic compartments
(Eugenin et al. 2009a, b;X ue ta l .2009). More importantly,
whether HIV-1’s presence in BC facilitates infection or if the
virus also engages in receptor-mediated “surfing” of conduits
as seen for herpes simplex and murine leukemia viruses
(HSVand MLV) (Dixit et al. 2008;S h e r e re ta l .2007)i sn o t
known. As for the latter, HSVand MLV bind to cell surface
receptors then travel to neighboring cells where fusion-
dependent entry ensues. Here, lateral movement of the lipid
bilayer coupled with internal actin retrograde flow facilitates
intercellular viral transfers (Sherer and Mothes 2008). HIV-1
may also be sequestered into endosomes then travel in BC
for intercellular spread. Recent evidence supports BC
endocytic transport of HIV-1 and other pathogens. This is
as follows. First, transfer of prions through conduits occurs
within lysosomes (Gousset et al. 2009). Second, for HIV-1, it
exploits endosome-BC trafficking pathways for its own
sustenance. Viral assembly and budding occurs in intracel-
lular vacuoles, late endosomes and multivesicular bodies
(MVB) (Deneka et al. 2007; Orenstein et al. 1988).
Macrophage endocytic compartments, such as late endo-
somes and MVB harbor infectious virus (Pelchen-Matthews
et al. 2003; Sharova et al. 2005). Third, macrophage not T
cell conduits support open-ended bidirectional exchange
of endolysosomal compartments between tethered cells
( S o w i n s k ie ta l .2008;O n f e l te ta l .2006). Although HIV-
1-macrophage interactions were extensively investigated,
the endocytic entry route for HIV-1 transfer was consid-
ered non-productive (Miyauchi et al. 2009; Uchil and
Mothes 2009). The ability of macrophages to establish BC
in vivo at times of robust antiretroviral immune responses
is important as the process could be exploited to accelerate
viral spread (Ciborowski and Gendelman 2006;E i l b o t te t
al. 1989;X ue ta l .2009).
In attempts to better understand how HIV-1 may use BC
for its spread, we studied the mechanism of intercellular
viral transfer. Our prior works investigated trafficking
through ER and Golgi networks. This was found necessary
for HIV-1 cell-to-cell transfer but the pathways and
regulatory processes remained ill defined (Kadiu and
Gendelman 2011). Thus to this end, we used proteomic,
immunologic and cell imaging assays to now demonstrate
that HIV-1 is sequestered into clathrin-coated pits then
sorted from early endosomes into non-degrading compart-
ments. This included, but was not limited to, Rab11
recycling endosomes and MVB. Actomyosin networks
regulated BC compartment mobility. The process occured
25 times faster than those recorded for “surfing” of
retroviruses on filopodia (Sherer et al. 2007). Endosomes
carry viral cargoes capable of viral gene expression. These
data provide novel mechanisms of HIV-1 spread seen
during host immune responses and show pivotal insights
into what need be overcome in realizing an effective
vaccine for viral elimination.
Methods
Antibodies (Abs) and reagents
Rabbit Ab to myosin II, charged MVB protein 4a
(CHMP4a) and goat Ab to Rab11 were purchased from
Santa Cruz Biotechnology (Santa Cruz, CA). Human Ab to
Gag (recognizes Gag
Pr55, p24, p17, matrix), gp120, gp160,
reverse transcriptase (RT), protease, integrase and the
TZM-bl cell line were obtained through the NIH AIDS
Research and Reference Reagent Program, Division of
AIDS, NIAID, NIH (Bethesda, MD). Rabbit Abs to a- and β-
tubulin and lysosome associated membrane protein 1
(LAMP1), as well as mouse and sheep Abs to HIV-1 gp120
werepurchasedfromNovusBiologicals,LLC(Littleton,CO).
Mouse Ab to LAMP1, early endosome antigen (EEA1),
HIV-1 p24 and human leukocyte antigen (HLA-DR) and
poly-D-lysine/fibronectin-coated LabTek chamber slides
were purchased from BD Biosciences (San Diego, CA).
Rabbit Abs to EEA1 and clathrin were purchased from
Cell Signaling Technologies (Danvers, MA). Rabbit anti-
m o u s ea n dm o u s ea n t i - g o a tsecondary Abs conjugated
to 6 nm gold particles were purchased from Electron
Microscopy Sciences (Hatfield, PA). The following
reagents were purchased from Invitrogen (Carlsbad,
CA): beta-galactosidase (ß-gal) staining kit, Click-iT
RNA Alexa Fluor 594 Imaging Kit, fluorescence in-
situ hybridization (FISH) Tag RNA multicolor kit,
rhodamine phalloidin, phalloidin Alexa Fluor 488 and
647, transferrin (Tfn) conjugated to Alexa Fluor 594,
anti-rabbit Alexa Fluor 488, 594,647, anti-mouse Alexa
Fluor 488, 594, 647, anti-sheep Alexa Fluor 488, anti-
human Alexa Fluor 488, 1,1’dioctadecyl-3, 3,3’,3’-
tetramethylindodicarbocyanine perchlorate (DiD),
3,3’dioctadecyloxacarbocyanine perchlorate (DiO), Pro-
Long Gold anti-fading solution with 4′,6-diamidino-2-
phenylindole (DAPI). Dulbecco’s Modified Medium
(DMEM) high glucose with GlutaMax, Dulbecco’s
Phosphate Buffer Saline (DPBS), Penicillin/Streptomycin
were purchased from Gibco/Invitrogen (Carlsbad, CA).
Wortmannin, brefeldin A (BFA), blebbistatin (BBST),
cytochalasin D (CD), nocodasole (Noc), dynasore,
dithiothreitol (DTT), 3-[(3-cholamidopropyl)-dimethy-
lammonio]-1-propane sulfonate (CHAPS), urea, thiourea,
bovine serum albumin (BSA), triton-X and protease
inhibitor cocktail were purchased from Sigma-Aldrich
(Saint Louis, MO). COBAS Amplicor HIV-1 Monitor
Test, v 1.5 was purchased from Roche Diagnostics
Systems, Inc (Brunchburg, NJ).
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(MDM)
Experiments with human peripheral blood mononuclear
cells (PBMC) were performed in full compliance of the
National Institutes of Health and the University of
Nebraska Medical Center ethical guidelines. Monocytes
from HIV-1, HIV-2 and hepatitis seronegative human
donors were obtained by leukophoresis, and purified by
countercurrentcentrifugalelutriation(Gendelmanetal.1988).
Experiments were performed utilizing primary human mono-
cytes (N=50 independent cultures). Monocytes were grown
in suspension cultures using Teflon flasks. Cells were cultured
in DMEM supplemented with 10% heat-inactivated human
serum, 100 units of penicillin and 100 μg/ml of streptomycin,
and 1,000 U/ml highly purified recombinant macrophage
colony stimulating factor (MCSF), a generous gift by Pfizer,
Inc., (Cambridge, MA). Cells were maintained at 37°C in a
5% CO2 atm for 7 d to permit for differentiation into MDM.
At day 7, MDM were exposed to the macrophage-tropic
strain HIV-1ADA at a multiplicity of infection (MOI) of 0.5
infectious viral particles/cell for 24 h. Prior to seeding in
mixed cultures (infected and uninfected MDM), HIV-1
infection was assessed by flow cytometry analysis of cells
stained for HIV-1 p24 FITC (Kadiu et al. 2007).
Virus isolation and labeling techniques
Virus isolation was performed as described (Kadiu et al.
2007). Enriched HIV-1 was labeled with 2 μM DiO or DiD
for 20 min in phosphate buffered saline (PBS) at 37°C.
Virus was resuspended in PBS and centrifuged twice at
100,000 × g on a 20% sucrose cushion to remove unbound
dye. For intercellular tracking of virus, labeled HIV-1 was
resuspended in culture medium and added to adherent
MDM in mixed culture prior to time-lapse microscopy.
Time-lapse confocal imaging
MDM grown in suspension were labeled with 2 μM DiD
(infected) and DiO (uninfected) for 20 min at 37°C in 5%
CO2. Unbound dyes were removed by washing three times
with DMEM supplemented with 10% heat-inactivated
human serum at 37°C. Cells were seeded on 35-mm
glass-bottom plates (MatTek Corporation, Ashland, MA)
in mixed cultures and subjected to live imaging at 37°C and
5% CO2. Images were taken in 5 s time intervals, using a
100× oil immersion objective attached to a Nikon TE2000-
U utilizing a Swept Field Confocal microscope (Nikon,
Tallahassee, FL). Brightness and contrast of the movies
were adjusted to improve visibility of particles associated
with BC. Imaging of particle movement in BC (from cell
body to cell body) was performed manually using the NSI
Elements software (Nikon). Particles with trajectories
shorter than 10 frames and moving out of focus during
recording were excluded from the tracking analysis.
Fluorescence in-situ hybridization
Alexa Fluor 488-labeled linearized Gag-Pol probes (2.2 kb;
Hind III-Kpn; Lofstrand Labs Limited, Gaithersburg, MD)
were generated using FISH Tag RNA Multicolor Labeling
Kit (Invitrogen). Probe labeling and in-situ hybridization
were performed per manufacturer’s instructions.
HIV-1 endocytic entry and intracellular trafficking
Adherent MDM were washed three times and incubated
with serum free medium for 30 min. Cells were
incubated for 30 min with either 100 μMo fd y n a s o r e
in serum-free medium or left untreated. Cells were
washed once with serum-free media, then DiD-labeled
HIV-1 together with fresh inhibitors was added to MDM
for 3 h at 37°C. Cells were washed three times in PBS,
mechanically detached using cell lifters (Thermo-Fisher
Scientific, Waltham, MA), fixed in 4% paraformaldehyde
(PFA) for 30 min and analyzed for viral uptake by flow
cytometry. Data was acquir e do naF A C S C a l i b u rf l o w
cytometer (BD Biosciences) using CellQuest Software
(BD Biosciences). For disruption of endocytic sorting,
MDM were plated for 3 h in mixed culture, followed by
treatment with 1 mM wortmannin and 0.5 mM BFA for
3 h. Cells were washed three times with PBS and fixed
with 4% PFA for 30 min. Immunostaining and confocal
analyses followed as described below.
Disruption of HIV-1 transport
For disruption of endosome motility, uninfected and HIV-1-
infected MDM were labeled with DiO (as described above)
and plated in mixed culture for 3 h to allow for contact
establishment. Cells were exposed to DiD-labeled virus for
1 h and then treated with 50 μM CD, Noc, or BBST for
10 min. Inhibitors were removed, and BC-dependent cell-
to-cell endosome transfer was determined by time-lapse
confocal microscopy and particle tracking analyses. A
group of inhibitor-treated and untreated unlabeled cells in
mixed culture were stained for HIV-1 Env and Gag and
myosin II and imaged by confocal microscopy.
Imaging of recycling compartments
MDM in mixed culture were seeded onto poly-D-Lysine-
coated chamber slides for 3 h devoid of human serum. Cells
were incubated with 1 μM Alexa 594-Tfn or DiO-labeled
HIV-1 for 1 h. Non-internalized particulates were removed
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4% PFA and imaged using the 63× oil lens of a LSM 510
confocal microscope (Carl Zeiss MicroImaging, LLC,
Thornwood, NY).
Metabolic labeling of RNA and proteins
Metabolic labeling and detection of newly synthesized
RNA was performed using Click-It RNA labeling kit per
manufacturer’s instructions (Invitrogen). Metabolic in-
corporation of 5-ethynyl uridine (EU) was extended to
24 h. Additional immunostaining and imaging of the
MDM was performed as described below.
Immunocytochemistry and confocal microscopy
For immunofluorescence staining, cells were washed three
times with PBS and fixed with 4% PFA at room
temperature for 30 min. Cells were treated with blocking/
permeabilizing solution (0.1% Triton, 5% BSA in PBS) and
quenched with 50 mM NH4Cl for 15 min. Cells were
washed once with 0.1% Triton in PBS and sequentially
i n c u b a t e dw i t hp r i m a r ya n ds e c o n d a r yA ba tr o o m
temperature. For MDM stained with multiple antibodies,
non-specific cross binding of secondary Abs was tested
prior to immunostaining. Use of secondary antibodies
originating or recognizing the same hosts was avoided.
Slides were covered in ProLong Gold anti-fading reagent
with DAPI and imaged using a 63X oil lens in a LSM 510
confocal microscope (Zeiss).
Enrichment of macrophage protrusions and proteomic
characterization
Enrichment of the macrophage protrusions was performed
as described with some modifications (Beckner et al. 2005).
Prior to BC collection, cells were maintained in Teflon
flasks and media was changed every 2 d to maintain the
infected MDM cultures metabolically stable. Cells were
then seeded on a 9 mm thick, 3-μm pore polycarbonate
filter of a Boyden chemotaxis apparatus (NeuroProbe,
Gaithersburg, MD) and maintained at 37°C in a 5% CO2
tissue culture incubator for 3 h. Prior to harvesting of BC,
each filter was first immersed in 100% methanol for 15 s
then placed with migrated cell materials (attached to the
undersurface of the filter) on a glass slide. Each filter was
firmly pressed against a glass slide to promote adherence of
migrated cellular processes. Cell bodies were wiped from
the filter top, and the filter was then gently peeled off the
slide with forceps. The processes were solubilized in lysis
buffer pH 8.5 [30 mM Tris HCl, 7M urea, 2M thiourea, 4%
(w/v) CHAPS, 20 mM DTT and 1X protease inhibitor
cocktail by pipeting. The remainder of the lysate was
allowed to crystallize on slides and harvested using razor
blades. One-dimensional gel electrophoresis, mass spectrom-
etry and database searches were performed as described
(Kadiu et al. 2009).
Scanning and transmission electron microscopy
MDMwereseededinmixedcultureonThermanoxcoverslips
(Thermo-Fisher Scientific) and allowed to establish BC for
24 h. Cells were then washed with PBS and fixed in 2%
glutaraldehyde and 2% PFA in 0.1M Sorensen’sp h o s -
phate buffer (SPB). Post-fixation cells were exposed to
1% osmium tetraoxide for 30 min and dehydrated at
50%, 70%, 90%, 95%, and 100% ethanol for 10 min.
Samples for transmission electron microscopy (TEM)
were embedded in Araldite. Coverslips were removed
and areas of the cell culture were selected for ultrathin
(60 nm thick) sectioning. Cells were sectioned on the
plane of the colony and in cross sections. Sections were
stained with uranyl acetate and lead citrate and observed
in a Tecnai G2 Spirit TEM (FEI Company, Hillsboro,
OR). Samples for scanning electron microscopy (SEM)
were critical point dried, mounted on specimen stubs and
sputter coated with 40 nm of gold/palladium. Samples
were observed with FEI Quanta 200 SEM (FEI Compa-
ny) operated at 25 kV. For immunogold labeling, MDM
in mixed infected and uninfected cultures were fixed
with 2% glutaraldehyde and 2% PFA in 0.1M SPB for
24 h. Cells were washed in PBS and permeabilized with
0.5% Triton-X and 3% BSA in PBS for 24 h then
incubated with primary Ab for 4 h at ambient tempera-
ture. Between incubation with gold conjugated Ab
(6 nm) for 2 h, MDM were washed three times in
0.5% Triton-X and 3% BSA. Cells were then post-fixed
with 2% glutaraldehyde and 2% PFA in 0.1M SPB and
processed for TEM as described above.
Enrichment of endocytic compartments
Immune isolation of endocytic compartments was
performed as previously described, with some modifi-
cations (Basyuk et al. 2003). MDM (400×10
6 cells)
were seeded in mixed cultures (uninfected and infected
MDM at equal ratios) and allowed to establish BC for
24 h (>90% of cell population connected by BC). Cells
were scraped in homogenization buffer (10 mM HEPES-
KOH, pH 7.2, 250 mM sucrose, 1 mM EDTA, and
1 mM Mg(OAc)2)a n dd i s r u p t e db y1 5s t r o k e si na
dounce homogenizer. Nuclei and unbroken cells were
removed by centrifugation at 800 × g for 15 min at 4°C.
Supernatant was layered on a 20% sucrose cushion and
centrifuged at 100,000 × g for 1 h. The pellet was
resuspended in 40% sucrose, 10 mM imidazole solution
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sucrose gradient and centrifugation at 100,000 × g at 4°C
for 1 h. The interfaces between 10% and 20% and 40%
and 35% sucrose bands containing enriched endocytic
compartments were collected and washed in PBS using
ultracentrifugation at 100,000 × g. Pellets were then
incubated with protein A/G paramagnetic beads (20 μlo f
slurry; Millipore) previously conjugated to endosome Ab
(10 μg of Ab) for 12 h at 4°C. Endocytic compartments
were washed and collected on a magnetic separator
(Invitrogen). For TEM imaging endocytic compartments
were fixed in 2% glutaraldehyde and 2% PFA in 0.1M
SPB for 3 h and then isolated by magnetic separation.
The bead-endosome pellet was then covered in agar and
processed for TEM as described above.
Reporter cell line
TZM-bl cells were cultured in DMEM supplemented with
10% fetal bovine serum, 100 units of penicillin and 100 μg/
ml of streptomycin. Cells were allowed to reach 70%
confluence, then detached by 25 mM trypsin/EDTA for
5 min at 37°C. Detached cells were cultured and allowed to
recover in 4 well poly-D-lysine LabTech chamber slides for
2 d or until they reached 40% confluence. Protein A/G
paramagnetic beads bound to isotype control Abs or
endocytic compartments (20 μl of slurry/500 μlo f
medium/well), and HIV-1 Tat protein (2 μM) were
reconstituted in supplemented DMEM and added to cells.
Replicate wells were pre-treated with 100 μM Efavirenz
(EFZ) for 24 h prior to exposure to endocytic compart-
ments. Chamber slides were placed on a plate magnet (Oz
Biosciences/Boca Scientific, Boca Raton, FL) for 24 h at
37°C in 5% CO2 after addition of endocytic compartment-
bead conjugates. The magnet was removed and cells were
washed three times with PBS and maintained in culture
medium for additional 48 h prior to β-gal detection (per
manufacturer’s instructions). Bright field images were
acquired using a Nikon Eclipse TE300 microscope (Nikon).
Quantitation of endosome viral load
RNAviral load for EEA1
+, Rab11
+, CHMP4
+ and LAMP1
+
immune-isolated compartments was measured using
COBAS Amplicor HIV-1 Monitor Test, v 1.5 and COBAS
AmpliPrep Instrument for automated specimen processing
(Roche Diagnostics) per manufacturer’s instructions.
Colocalization tests and statistical analyses
Quantitation of immunostaining and Pearson’s colocalization
coefficients was performed with ImageJ software, utilizing
JACoP plugins (http://rsb.info.nih.gov/ij/plugins/track/jacop.
html) (Bolte and Cordelieres 2006). Comparison was
performed on 7–10 sets of images (whole cells) acquired
with the same optical settings. To improve visibility of
subcellular compartments in the BC, brightness and contrast
settings were changed for the entire image in select images
using Adobe Photoshop. Graphs and statistical analyses were
generated using Excel and GraphPad Prism. Two-tailed
Student’s t-tests were used for all data and the error bars
are shown as ± S.E.M., unless noted otherwise. Results were
considered significant at P<0.05.
Results
BC speeds communication between MDM
We first assessed the abilities of BC to affect exchange
between infected and uninfected MDM. This was done
first by measures of the dynamics of contact formation
between cells. Cells were propagated in suspension
Teflon cultures in complete media containing MCSF.
Half of the cells were infected with HIV-1ADA at a MOI
of 0.5 infectious viral particles/cell and the second half
were uninfected. After 7–10 days, greater than 96% of
cells within the infected cultures were HIV-1p24 positive
(as assayed by flow cytometry, Fig. 1a). At that time, the
infected and uninfected MDM were mixed at equal ratios.
These were defined as mixed cultures. BC formation
between infected and uninfected cells was confirmed by
confocal imaging of mixed cell cultures immunostained
for HIV-1 Env glycoproteins (gp120/gp160) and micro-
tubules (alpha/beta tubulin). Images showed cellular
protrusions connecting HIV-1 Env
+ (red) to Env− (green)
uninfected MDM (Fig. 1b, arrows). BC frequency was
measured in mixed cell cultures at 30, 60 and 180 min and
was time dependent. Number of cells connected by BC
increased significantly at 60 (P<0.0001) and 180 min (P=
0.0077; Fig. 1c). At 180 min BC displayed tubular
morphologies (Fig. 1d, arrows). Unlike T cell conduits
that form as two touching cells which move away from
each other (Sowinski et al. 2008), macrophage BC extend
from one cell to their target and display three-dimensional
flagellum-like movements (Movie S1). Their length and
diameter average 110±57 μma n d7 ± 4μm( m e a n±S . D . ,
n=238 cells; Fig. 1e,f). BC were distinct from non-
tethered protrusions used by macrophages for cell
migration, which include bulbous lamellipodia (Fig. S1A) or
thin and short filopodia (Movie S2) (Lundquist 2009; Vonna
et al. 2007). To best visualize BC-mediated communications,
uninfected and infected MDM were labeled with DiO
(green) and DiD (red) lipophilic dyes, respectively. Such
dyes are sequestered into endocytic compartments and
can be used to measure long-term endocytic trafficking
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this task, DiO- and DiD-labeled cells were removed from
suspensions and plated in mixed culture. Time-lapse
images at 30 min during adherence demonstrated that
virus-infected MDM readily generated BC. Particle tracking
showed that endosome transfer through BC occurred
immediately after cell contact at 1.0±0.7 μm·s
−1 (mean ±
S.D., n=80 particles; Fig. 1g,h). MDM in “pure” infected
and in mixed infected and uninfected cultures displayed
increased intra- and intercellular endocytic traffic when
compared to uninfected cells alone (Movies S3–S5). Since
both BC and secreted vesicles contribute to intercellular
communication, lipid transfer activity was measured in the
presence (adherent cultures) and absence (suspension
cultures) of BC (Simons and Raposo 2009). Overall lipid
transfer peaked at 180 min, with 42% of the cells displaying
dual dye labeling. Of these only 19% acquired dual
fluorescence through BC. Together these data demonstrate
that macrophage BC connect infected to uninfected cells.
HIV-1 constituents in BC
We next asked whether HIV-1 constituents are present
in the conduits. This is a seemingly important question
for viral spread and likely present as BC facilitate
transfer of cellular material between infected and
uninfected MDM. Punctate distribution of HIV-1
RNAs in BC and cell body was visualized by
fluorescence in situ hybridization. This was visualized
by HIV-1 Gag-Pol probes labeled with Alexa Fluor
488 (Fig. 2a, inset boxes 1 and 2). Whole cell and viral
RNA metabolically labeledwith 5-ethynyl uridine-Alexa
Fluor 594 was co-distributed with Env, Gag and RT
within large compartments in BC (Table S1). Env, capsid
(Gag including Gag
Pr55,p 2 4 ,p 1 7 ,m a t r i x ) ,R T ,i n t e g r a s e ,
protease, Tat and Vif were readily identified in BC
(Fig. 2b–h). Interestingly, such BC-associated viral con-
stituents appeared as large particulates (0.5–2.5 μmi n
diameter) and were confined to the BC cortical actin
(phalloidin-Alexa Fluor488; Fig. 2e–h;T a b l eS 1). These
data demonstrate that HIV-1 constituents (HIV-1 proteins
and viral RNA) are present in macrophage BC.
HIV-1 is sequestered into endosomes
The presence of HIV-1 Env-CD4 complexes in the
conduits would suggest that virus exploits receptor-
dependent “surfing” on BC to reach neighboring target
cells (Martin and Sattentau 2009;S o w i n s k ie ta l .2008).
We then asked whether such a manner of viral transport
would require mature progeny HIV-1 on the exterior of
BC. Thus, the presence of CD4-Env complexes associated
with macrophage conduits was assessed. Confocal imag-
ing of MDM identified large particulates (0.5–2 μm) of
CD4
+ and Env
+ in the conduits (Fig. S2A, inset boxes 1
and 2). SEM revealed BC tubular morphologies and its
plasma membrane sheathing of vesicle-like compartments
(Fig. 3a,b). TEM revealed heterogeneous populations of
BC containing endocytic vesicles varying in coating, size
and electron densities (Fig. 3c, inset 1 and arrows). Plasma
membrane microvesicles were on the surface of the BC
(Fig. S2B). Fifty-five cross-sections (60 nm thick) of
MDM in mixed cultures were generated (n=5 independent
experiments). Mature virions were identified in the
extracellular space of ten sections (Fig. S2C, inset 1, red
arrow), however none were observed anchored to the BC
plasma membrane (n=70 conduits imaged). Disruption of
BC using microflament and microtubule inhibitors CD and
Noc, respectively suppressed productive infection at
similar levels to the protease inhibitor Atazanavir (ATV).
Treatment with neutralizing antibodies did not alter levels
of HIV-1 infection or its presence in the BC (Fig. S2D).
On the contrary early endosomes containing anti-Env
A ba n dC D 4w e r er e a d i l yi d e n t i f i e di nt h eB C
(Fig. S2E, F). Interestingly, inhibition of clathrin-
dependent endocytosis blocked uptake of fluorescently
labeled HIV-1 (Fig. S2G). HIV-1 and CD4 were present
within large clathrin
+ compartments in the cell body and
BC (Fig. S2H, arrows). TEM imaging of immunogold-
labeled mixed MDM cultures showed Gag (Gag
Pr55,p 2 4 ,
p17, matrix) punctate staining of endocytic vesicles
(arrows indicate gold-laden compartments). In some instan-
ces, capsid-like morphologies were observed within these
same structures (Fig. 3d, blue arrow). These data, taken
together, suggested that BC-associated HIV-1 was seques-
tered into endocytic compartments.
Fig. 1 BC sustain communication between uninfected and infected
MDM. a Assessment by flow cytometry of HIV-1 infection in single
culture MDM. b Formation of BC between infected and uninfected
MDM labeled for HIV-1 envelope (red) and microtubules (green).
Observe presence of HIV-1 Env along the conduit (scale bars,1 0μm,
inset, 5 μm). c Frequency of BC formation in MDM uninfected,
infected and mixed cultures (equal ratios of uninfected and infected
MDM) at 30, 60 and 180 min in adherence (n=450 cells/group, error
bars ± S.E.M). Data are representative of five independent experi-
ments. d Bright field images of conduits connecting MDM in mixed
culture. Arrows indicate tethering sites (scale bar,1 0μm). e, f
Frequency of conduit length and diameter observed in MDM mixed
populations (n=238 cells). g Time-lapse confocal images showing
contact establishment and lipid transfer through BC from infected
(DiD-labeled, red) to uninfected (DiO-labeled, green) MDM. h Veloc-
ity of lipid transfer through the BC. Graph reflects average velocity
values recorded at each time point for 80 particles tracked along the
BC (error bars ± S.E.M.). i Intercellular transfer activity in mixed
MDM in presence (adherent cultures) and absence (suspension
cultures) of conduits. Ratios of cells affected by this process over
time (yellow, upper right quadrants) compared to the overall red
(DiD-labeled infected MDM, upper left quadrants) and green
populations (DiO-labeled, uninfected MDM, lower right quadrants)
are shown in bold
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We next sought to identify the intercellular transport
compartments for HIV-1. To this end, we characterized the
proteome of the macrophage conduits. To mimic formation
of BC in mixed cultures, HIV-1-infected MDM were seeded
on a filter membrane separating them from the lower
chamber of a Boyden chemotaxis apparatus containing
uninfected MDM-conditioned medium (Fig. S3A–B).
Figure 3e shows infected MDM extending their processes
664 J Neuroimmune Pharmacol (2011) 6:658–675through filter pores unto the lower chamber (arrows).
Protrusions were mechanically detached from the cell
bodies and visualized by bright field and confocal micros-
copy (Fig. S3C, D). Proteomic characterization of enriched
conduits identified early, late and recycling endosomes,
MVB, lysosomes and actin-binding proteins. Regulators of
endocytic sorting, including Rab GTP-ases (Rab1, 2, 5, 7a,
11a) and late endosome-lysosomal markers (annexin II and
IV, MHCI, MHCII, as well as ubiquitin and cathepsin
isoforms) (Jouve et al. 2007; Zerial and McBride 2001)
accounted for 13% of the conduit proteome (Fig. 3f; Table
S2). Proteins driving endosome movement and regulators
of actin stress fibers such as myosin motor proteins IC, II,
light chain (LC) 6 and heavy chain (HC) 9, together with
other actin-binding proteins represented 14% of the overall
proteome, while HIV-1 proteins accounted for 4%. These
findings indicated that active endocytic transport of HIV-1
occurred in the macrophage conduits.
Endosomes, HIV-1 and BC
Next, we examined HIV-1 distribution within individual
endocytic compartments of the BC. MDM were exposed to
DiD- or DiO-labeled HIV-1 for 3 h. Equivalent numbers of
uninfected MDM were added and allowed to establish BC
between adherent cells. Cells were then fixed and immu-
nostained for endosome markers that included EEA1 for
early endosomes, HLA-DR for MVB and LAMP1 for late
endosomes/lysosomes. For tracking of HIV-1 with recycling
endosomes, MDM were exposed to both fluorescently
Fig. 2 HIV-1 constituents are identified in the BC. a Detection by
fluorescence in-situ hybridization of viral RNA using Alexa Fluor488-
labeled HIV-1 Gag-Pol probes (green). Confocal and differential
interference contrast (DIC) images show presence of HIV-1 RNA in
the cell body and conduits (insets 1 and 2). b–d HIV-1 Env (green),
Gag (Gag
Pr55, p24, p17, matrix; green), RT and RNA Alexa Fluor594
(red, metabolically-labeled with 5-ethynyl uridine) are readily visible
in the conduits. (Refer to Table S1 for newly synthesized RNA and
viral protein co-localization coefficients). e–h HIV-1 protease (red),
integrase (red), Tat and Vif (red) are present in the BC. Staining for
cortical actin (phalloidin-Alexa Fluor 488) and nuclei (DAPI, blue)
was performed to distinguish MDM connected by the conduits from
polarized single cells (scale bar,1 0μm; inset, 5 μm)
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labeled HIV-1 was observed within multiple endocytic
compartments (Figure S4A–C). However, Pearson’s coloc-
alization test indicated preferential association of HIV-1
Fig. 3 Ultrastructural and biochemical characterization of BC. a, b
SEM image of macrophage conduit reveals vesicle-like structures
sheathed by plasma membrane. c TEM image of a sectioned conduit
shows coated and uncoated vesicles of various sizes and electron
densities, and large lipid droplets (inset 1 and 2, arrows). d TEM
image of BC cross-sections generated from polarized MDM in mixed
culture. Cells were immunostained for HIV-1 Gag. Secondary Ab
conjugated to 6 nm gold particles was used for detection. Arrows (red)
indicate endocytic compartments laden with gold particles. Rare
capsid-like dense structures were observed in endocytic vesicles (blue
arrow). e SEM image of infected macrophages seeded in the upper
chamber of a Boyden chemotaxis apparatus, extending their processes
through a polycarbonate porous membrane towards the lower chamber
(arrows). f Classification by function of the proteins identified with
two or more significant (P<0.05) and unique peptides in the BC
proteome (pooled sample from five independent experiments). Refer
also to Table S2 for a list of proteins identified in the conduits
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MVB (82±0.1%; mean ± S.E.M; Fig. S4A–C). Since, HIV-
1 uncoating can occur in early endosomes, tracking of
fluorescently labeled HIV-1 (envelope-labeled with lipo-
philic dyes) into endocytic compartments may not reflect
the fate of all viral constituents (Miyauchi et al. 2009).
Therefore, we investigated endocytic sorting of each viral
constituent (Env, Gag and RNA) separately. Similar to
fluorescently labeled HIV-1, Env, Gag and RNA were
readily identified within early endosomes, MVB, recycling
endosomes (Rab11a) and lysosomes in the BC (Fig. 4a–k).
CHMP4a was used as an MVB marker instead of HLA-DR,
as HLA-DR is abundantly present in both the HIV-1 envelope
and MVB (Ott et al. 2000). CHMP4a is a member of the
endosomal-sorting complex required for transport
(ESCRTIII) family, which together with tumor susceptibility
gene 101 (Tsg101) regulates early endosome-to-MVB sort-
ing and HIV-1 budding within MVB (Babst et al. 2002;
Deneka et al. 2007; Welsch et al. 2007). Immunostaining for
Rab11a, a regulator of fast (Tfn receptor) and slow endocytic
recycling, was performed to expand detection of recycling
endosome populations (Trischler et al. 1999). Metabolic
labeling of RNA (cellular and viral) was chosen over FISH
(gag-pol probes) since tissue degradation by proteinase K
during FISH interferes with additional immunostaining for
endocytic markers. Env, Gag and RNA were present at
varying levels in BC endosomes. However, significant (P<
0.05) levels of Env were seen within early and recycling
endosomes (Fig. 4l). Gag and RNA preferentially (P<0.05)
colocalized with MVB and Rab11 endosomes (Fig. 4m,n).
Intra- and intercellular trafficking of HIV-1 constituents
in MVB-Rab11 recycling endosomes
Having identified Env, Gag and RNA in several endosome
populations and their preferential distribution with recy-
cling endosomes, we next queried whether HIV-1 sorting
routes converged with the recycling pathway. Endosomes
and lysosomes may undergo partial fusion with late and
recycling endosomes to form temporary recycling hybrid
compartments targeted for the plasma membrane (Blott and
Griffiths 2002; Bright et al. 1997; Luzio et al. 2005). This
process would explain the overlap in endocytic distribution
of HIV-1. Indeed, partial colocalization of EEA1 (54±2%),
LAMP1 (34±1%) and CHMP4a (34±2%; mean ± S.E.M.,
n=80 cells/group) was observed with Rab11
+ compart-
ments. In addition, endosomes carrying both early endo-
some and MVB markers were also identified (Figure S5A–
C). Disruption of MVB biogenesis using wortmannin
(Gruenberg and Stenmark 2004) and endocytic recycling
with BFA (Wang et al. 2001) caused aggregation of Gag in
large perinuclear vacuoles and excluded Gag from the BC
(Figure S5D, E). Collectively, these findings demonstrate
that dissemination of HIV-1 constituents through the
conduits occurs within endosomes and is regulated primar-
ily by the MVB-Rab11a recycling route.
Endocytic compartments carry infectious virus
Although intercellular transmission of retroviruses by
cellular extensions has been estimated at 100–1,000 times
faster than cell-free virus, it is unknown whether this mode
of viral dissemination results in infection (Martin and
Sattentau 2009; Sowinski et al. 2008). Previous studies
have shown that HIV-1 sequestered within macrophage
endocytic compartments is infectious (Pelchen-Matthews et
al. 2003; Sharova et al. 2005). Therefore, we tested whether
this was the case for endocytic compartments in polarized
macrophages. MDM (>90% of cell tethered by BC) were
mechanically disrupted and the endosome fraction was
collected by sucrose gradient. Protein A/G magnetic beads
conjugated with Ab to EEA1, CHMP4a, Rab11a Ab, and
LAMP1 were incubated with the endosome fraction and
isolated by magnetic separation (Fig. 5a). Protein A/G
paramagnetic beads conjugated to pooled isotype control
antibodies were used to preclude non-specific binding of
other subcellular membranes. Enrichment of endocytic
compartments was confirmed by TEM. Figure 5b shows
high electron density endosomes bound to a magnetic bead
(inset 1, arrows).
Next, we determined the viral load (HIV-1 RNA copies)
in each isolated endosome population. COBAS Amplicor
analysis showed endosomes carried high viral loads (∼10
4
HIV-1 RNA copies/μg of Ab; Fig. 5c). Numbers of HIV-1
RNA copies were distinct for each endosome population
(Fig. 5c). Rab11 endosomes displayed the highest viral load
(3.2×10
4 RNA copies/μg of Ab) further supporting the role
of the recycling pathway in viral trafficking. HIV-1 viral
load for the isotype control pool was at background level,
thus excluding non-specific binding to other virus-
containing membranes. To establish infectivity of endocytic
viral cargo, we used a TZM-bl reporter cell line, which
contains an integrated copy of the ß-gal gene under control
of the HIV-1 promoter (Platt et al. 1998). In MDM
connected by BC, we and others have observed a seamless
flow of endosomes between infected (DiO-labeled) and
uninfected cells (DiD-labeled cells; Fig. S6A, B) (Onfelt et
Fig. 4 Distribution of HIV-1 constituents with BC endocytic compart-
ments. a–k Confocal images of MDM in mixed culture showing
distribution of HIV-1 Env (red, panels a, c, d and blue, b), Gag (green,
b and red, e–g), metabolically labeled RNA (red) with early
endosomes (green), MVB (green), recycling endosomes (green), and
lysosomes (green) identified in the conduits (scale bars,1 0μm;
insets, 5 μm). l–n, Pearson’s colocalization tests of HIV-1 Env, Gag
and RNA distribution with BC endocytic compartments. Pearson’s
colocalization coefficients were converted to percent overlap between
fluorophores (error bars ± S.E.M., n=80 cells)

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preserve their characteristics or fuse with native endosomes
(encircled yellow). To test infectivity of endocytic cargoes,
we mimicked direct access of endosomes to the intracellular
milieu of the target cells. To accomplish this, we considered
the following limitations: First, the TZM-bl reporter cell
line has limited phagocytic characteristics and the immune
isolated endosomes do not carry surface molecules (i.e., Fc
receptors) necessary for internalization. Therefore, this
excluded the possibility of receptor-mediated endocytosis
as a mode of introducing the isolated compartments to the
intracellular environment of TZM-bl. Second, isolated
endosomes remain attached to the bulky magnetic beads
(10–15 μm in diameter) that constituted a large cell entry
barrier. Therefore, to gain access into the cytoplasm of the
target cells (as it would occur via open-ended BC),
endosome-bead complexes were forced into the TZM-bl
by exposure to strong magnetic fields (Fig. 5a). Integration
and expression of viral genome were confirmed by ß-gal
detection (blue) at 72 h post-exposure (Fig. 5d,e). Cells
exposed to Rab11a and CHMP4a endosomes induced similar
levels of ß-gal as those observed with cell-free HIV-1 (P>
0.05). The infectivity of early endosomes and lysosomes
was measured at significantly lower levels than cell-free
HIV-1 (P<0.001, Fig. 5g). Since, HIV-1 Tat
+ compartments
were identified in the BC, we questioned whether the
expression of ß-gal could be induced by Tat alone. TZM-bl
were exposed to 2 μM recombinant Tat for 24 h and then
stained for ß-gal. Tat treatment altered the cellular morphol-
ogy of TZM-bl compared to untreated uninfected cells;
however similar to control exposure, Tat alone did not induce
ß-gal expression (Fig. 5d). Pre-treatment of TZM-bl with
EFZ (a non-nucleoside reverse transcriptase inhibitor) prior
to endosome exposure significantly (P<0.0001) reduced ß-
gal expression (Fig. 5f,g). These findings indicate infec-
tious viral cargoes are preserved within endosomes and
are capable of inducing bona fide infections.
HIV-1 is transported through the BC in non-degrading
endocytic compartments
Next, we examined the role of endosome transport in viral
propagation. MDM labeled with DiD were exposed to
fluorescently labeled HIV-1 and allowed to establish viral
transfer through the conduits to the uninfected cells (Movie
S6). Alternatively, cells exposed to DiO-HIV-1 were treated
with CD, Noc and BBST. CD and Noc were tested for
inhibition of endocytic transport due to involvement of
actin tails and microtubules in the propulsion of endosomes
(DePina and Langford 1999).
BBST, a non-muscle myosin II inhibitor, was used to
test myosin II-dependent transport of viral constituents.
Among the myosin isoforms identified in the BC
proteome, myosin II was further investigated due to its
high co-distribution with viral proteins (Fig. 6a)a n d
endocytic compartments (Fig. S7A–D). Cells exposed to
HIV-1 alone and to CD, Noc or BBST were subjected to
viral particle tracking analysis by still and time-lapse
confocal imaging. Treatment with inhibitors induced
aggregation of HIV-1 Env/Gag in the perinuclear region
in CD- and Noc-treated MDM and large vacuoles in
BBST-treated cells (Fig. 6b). In untreated cells the
velocity of viral transfer averaged at 1.1±0.1 μm·s
1
(mean ± S.E.M., n=70 particles). Exposure to CD, Noc, or
BBST significantly suppressed endosome movement at
each time point, including average velocity (P<0.0001),
path length (P<0.0001) and displacement (P<0.0001, n=
70 particles/group) compared to untreated cells (Fig. 6c–e).
Together these findings demonstrate that cell-to-cell spread
of HIV-1 through BC is dependent upon the integrity of
endocytic and actin-myosin networks.
Discussion
We demonstrated that unlike other retroviruses that “surf”
cellular protrusions, HIV-1 exploits endocytic traffic
through bridging conduits for its intercellular spread. In
previous studies, viral endocytic entry was shown to effect
the viral life cycle (Martin and Sattentau 2009; Uchil and
Mothes 2009). HIV-1 enters the cell by clathrin-mediated
endocytosis and uncoating, occurs in endocytic compart-
ments (Miyauchi et al. 2009). Indeed, genomic screens for
host proteins required for infection demonstrate a depen-
dency of HIV-1 replication on the integrity of the endocytic
networks (Brass et al. 2008). HIV-1 intracellular endocytic
trafficking is linked to viral assembly and budding. The
latter occurs within the MVB and in the endoplasmic
reticulum and Golgi membranes (Orenstein et al. 1988;
Pelchen-Matthews et al. 2003). Although endolysosomal
compartments are in BC, specific endocytic pathways and
endosome sub-types used for intra- and intercellular viral
Fig. 5 Endocytic compartments carry infectious viral cargo. a
Illustration of immunoisolation of endocytic compartments from
polarized MDM in mixed culture and their magnet-induced entry in
TZM-bl reporter cell line. b TEM of enriched endocytic compartments
bound to paramagnetic beads. Arrows indicate high-density endo-
somes. c HIV-1 viral load (RNA copies) in early endosomes,
lysosomes, MVB and recycling endosomes and isotype control Abs.
d, e Representative bright field images of uninfected TZM-bl, cells
exposed to HIV-1 Tat, cell-free HIV-1, and immune-isolated endocytic
compartments expressing different levels of ß-gal (blue) at 72 h post-
exposure. Arrows indicate paramagnetic beads (brown) within TZM-
bl. f Representative images of TZM-bl showing susceptibility of cell-
free and endocytic HIV-1 infection to antiretroviral treatment. g
Quantiation of overall endosome infectivity and susceptibility to
antiretroviral therapy (efavirenz) in TZM-bl (scale bars 100 μm; error
bars, ± S.E.M., n=400 cells/group, N=2 independent experiments)
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and Mothes 2009) until now.
Herein, we explored intra- and intercellular HIV-1
macrophage endocytic trafficking routes. It is as follows.
Intracellular transport begins with receptor binding and
internalization into clathrin-coated pits. This is followed by
viral recruitment into early sorting endosomes representing
large tubular networks directing downstream endocytic
sorting (Christoforidis et al. 1999; Maxfield and McGraw
2004). Viral uncoating may occur at this stage, explaining
the absence of mature HIV-1 in the BC or within endocytic
vesicles (Miyauchi et al. 2009). From the early sorting
endosomes, viral constituents may undergo a range of
processing routes and may be targeted to the MVB. These
represent a subpopulation of late endosomes that serve as
intermediate stations for recycling and secretion (de Gassart
Fig. 6 Dependence of viral transfer on integrity of endocytic
transport. a, b Distribution of myosin II with HIV-1 Env and Gag, in
MDM untreated or exposed to CD, Noc or BBST post-formation of
BC (scale bar,1 0μm). c–e Disruption of endosome/viral motility by
CD, Noc or BBST. Progressive average movement was determined
using the mean velocity (μm•s
−1), path length (μm), and displace-
ment from the origin for all analyzed particles (error bars,±S . E . M . ,
n=70 particles/group, N=3 independent experiments) at each time
point for 120 s
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also undergo maturation here and then following fusion
with Rab11 endosomes virus, is recruited to, and then
released from the plasma membrane (Maxfield and
McGraw 2004; Pelchen-Matthews et al. 2003). Possible
back fusion of lysosomes and MVB with Rab11 compart-
ments would explain viral targeting to MVB and
“secretory” or non-degrading lysosomes. This is followed
by viral trafficking to the plasma membrane where
exosome and protein exocytosis occur (Maxfield and
McGraw 2004; Pelchen-Matthews et al. 2003). Early
endosomes may also fuse with Rab11 and be directed to
the perinuclear region and into the endocytic recycling
compartment (Maxfield and McGraw 2004). These can
then target to the plasma membrane of effecter cells for
HIV-1 assembly or transport through bridging conduits to
uninfected cells. Such HIV-1 intra- and intercellular
sorting pathways are summarized in Fig. 7.
What targets viral constituents to a neighboring cell
requires further investigation. Previous studies demonstrated
the presence of antigen-presenting MHCII-CD4 complexes
and HIV-1 proteins in BC formed between macrophages,
B cells and T cells in lymph nodes (Brown et al. 2008;
Chinnery et al. 2008;X ue ta l .2009). Proteomic and
confocal analyses also identified these proteins in the
macrophage BC. Since HLA-DR is the most abundant
protein in the HIV-1 Env, it is likely that processing of
HIV-1 may be guided by CD4-HLA-DR endocytic
Fig. 7 Pathways of macrophage intra- and intercellular HIV-1
trafficking. HIV-1 receptor-mediated entry is regulated by clathrin-
coated pits (Miyauchi et al. 2009). Upon inhibition of dynamin by
dynasore, viral entry is blocked. Clathrin-coated vesicles containing
HIV-1 may undergo Rab5/EEA1-dependant fusion with the early
sorting endosome(Bucci et al. 1992; Zerial and McBride 2001).
Endosomes can pinch off the vesiculo-tubular network also termed
early sorting endosome (Maxfield and McGraw 2004) and undergo the
following downstream sorting routes: a fuse with the endocytic
recycling compartment (ERC; perinuclear region) and then undergo
Tfn-like Rab11-mediated recycling to the BC and plasma membrane
(Maxfield and McGraw 2004). Disruption of this processes by
brefeldin A results in accumulation of HIV-1 constituents in large
cytosolic compartments (Wang et al. 2001). b undergo sorting to the
MVB for ILV biogenesis, virus assembly and budding regulated by
ESCRT family (Babst et al. 2002; Garrus et al. 2001; Gill et al. 2007).
MVB in turn may undergo fusion with Rab11 endosomes to be
transported either to the plasma membrane for exosomal release
(Simons and Raposo 2009) or intercellular transfer through the
conduits. Disruption of MVB biogenesis by wortmannin results in
agregation of HIV-1 constituents in large vaccuoles (Gruenberg and
Stenmark 2004). Lysosomes may undergo backfusion with MBV and
Rab11 compartments to be targeted at the plasma membrane (secretory
non-degrading lysosomes; (Blott and Griffiths 2002; Luzio et al.
2005) or the bridging conduits. In parallel to endocytic entry and
intercellular trafficking, virion-plasma membrane fusion may also
occur followed by uncoating, reverse trancription, formation of pre-
integration complexes (PIC), and RNA expression (Brass et al. 2008).
Thick blue arrows indicate trafficking routes that target HIV-1 directly
to the conduits
672 J Neuroimmune Pharmacol (2011) 6:658–675processing (Callahan et al. 1993;O t te ta l .2000). This
could explain similarities in HLA-DR processing routes
and trafficking of viral constituents within MVB recycling
compartments (Fernandes et al. 2000;R a p o s oe ta l .2002;
Romagnoli et al. 1993). These processes may be relevant
for viral spread in vivo. HIV-1 may exploit the high
mobility and antigen presentation characteristics of macro-
phages as a “Trojan Horse” for immune escape and
dissemination.
Equally important issues remain; such as, can infectious
virus be transmitted ell-to-cell from within endocytic
compartments and does this mode of viral transfer result
in the productive infection? MVB are likely infectious
(Pelchen-Matthews et al. 2003). Our works demonstrate
that in addition to MVB, which may carry HIV-1, early and
recycling endosomes and lysosomes also transmit viral
RNA and proteins. Regardless of abundant presence of
HIV-1 constituents and RNA within endosomes, we were
unable to identify mature HIV-1 within BC and immune
isolated endosomes. Mature HIV-1 was frequently observed
in the extracellular space. Instead, high-density endocytic
compartments were easily identified and those carrying
capsid-like structures were rarely observed. Although we
performed extensive TEM analysis, we do not exclude the
possibility that BC endocytic compartments could also
carry mature HIV-1. However, there was a discrepancy
between the viral loads and infectivity of endocytic
compartments as well as our inabilities to observe mature
virus by ultrastructural tests. We posit that a potential
alternate route of HIV-1 dissemination and productive
infection through the conduits could exist. This would
involve sequestration of HIV-1 in endocytic compartments
followed by uncoating and content mixing (Miyauchi et al.
2009). These viral cargoes would then be shuttled to
uninfected target cells where viral components, although
disassembled, could be capable of initiating infection.
If this were the case, then how is viral material
unloaded from the endosomes to the cytosol of target
cells? Recent studies on the MLV replication cycle have
shown that Rab11 endosomes carrying MLV RNA have
the ability to fuse with or bud from the cytosol either to
release RNA in proximity to the nucleus or transport
newly synthesized viral RNA to the plasma membrane
(Basyuk et al. 2003). Similar to MLV, our data show that
HIV-1 and cellular RNA primarily traffick within and
between cells by Rab11 recycling endosomes. This
would also explain how viral material gains access to
effector cell endosomes and to target cell cytosol via BC.
In addition to the relay of viral constituents by direct
endosome-endosome fusion (clathrin pits-early endosomes-
early endosomes-recycling endosomes or MVB-recycling
endosomes), it is likely that budding and fusion of
Rab11 with the cytosol allow loading of newly
synthesized and original viral constituents into endo-
somes along with subsequent unloading into uninfected
cells via BC-mediated transport. This process may be
facilitated by seamless flow of endocytic compartments
between BC-connected cells. Indeed, we observed that
upon reaching the target cells, endosome transport was
not interrupted and these compartments either fused
with autochthonous endocytic compartments or pre-
served their original membranes. Additionally, connected
polarized cells were observed to share organelles such
as ER and Golgi (our unpublished observations).
Formation of a cellular network that precedes and can
lead to syncytium formation may allow the connected
cells to function as a unicellular organism (Kadiu et al.
2007). Therefore, processes of viral assembly, maturation,
release (in the effecter cell) as well as entry, and
disassembly (in the target cells) are voided, thus reducing
both transfer time and exposure to the host immune
system (Martin and Sattentau 2009). Nonetheless, the
infectivity of disassembled virus has not been previously
reported.Processingofviral constituentsintooverlapping,yet
different sorting routes suggests such a mode of viral transfer
may exist and represents a barrier in designing efficient and
targeted therapeutic strategies against HIV-1 infection.
Alternatively, HIV-1 may be trafficked from cell to
cell within endosomes. We posit that four potential
mechanisms may account for intercellular transfer of
virus. First, MDM become productively infected, and
newly synthesized virus gains access to intracellular
membranes of neighboring cells where they are assembled
and then transported to uninfected cells. This is however
not very likely to occur since metabolic tracing of newly
s y n t h e s i z e dH I V - 1E n va n dG a gr e v e a l e dt a r g e t i n go ft h e s e
proteins to the plasma membrane rather than the conduits
(our unpublished observations). Second,H I V - 1c o u l db e
internalized by a polarized macrophage during secondary
infection or “superninfection”. Internalized virus may
be then directly “recycled” to adjacent cells. Third,
macrophages could “archive” mature HIV-1 progeny in
endocytic compartments and upon contact, transfer HIV-
1-containing compartments through BC to uninfected
cells. Fourth, although HIV-1 was distributed primarily
with non-degrading compartments, we cannot exclude the
possibility that transfer of HIV-1 to the uninfected cell
may be driven by apoptosis of the effecter cells. Natural
killer cells use conduits as a means for transfer of
apoptotic bodies from dying cells (Chauveau et al.
2010). A similar process may occur in macrophages, as
a function of their phagocytic and debris clearing
activities. Although, low levels of cell death were
measuredinpolarized MDM mixed cultures(ourunpublished
observations), uninfected MDM were often observed to
form contacts with multinucleated giant cells. Therefore
J Neuroimmune Pharmacol (2011) 6:658–675 673it is likely that endocytosed HIV-1 or progeny assembling
in intracellular membranes during the initial stages of cell
death may exploit transport of apoptotic bodies through
the conduits as a means of survival. We posit that
transmission of replication competent virus and transfer
of viral constituents could occur in tandem. The
processes that drive HIV-1 intercellular transfer by direct
cell–cell contact nonetheless requires further investigation.
Whether or not alternative transfer of viral constituents
facilitatethe viral lifecycle orperhapsinciteinfectionremains
an open question.
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